Recent Advances in Lipid-Based Nanoformulations for Breast Cancer Theranostics

Abstract

Breast cancer is one of the principal causes of cancer deaths across the world. Chemoresistance, bioavailability issues and off-target effects are the significant limitations of conventional therapeutic agents in treating breast cancer. In recent years, researchers have concentrated on creating nanomedicine platforms to overcome the limitations associated with traditional anticancer therapies. Simultaneous diagnosis and treatment (theranostics) of cancer using custom-designed nanomedicines is one of the critical advancements in cancer research. Among various nanocarriers, lipid-based nanotheranostics have multiple advantages like biocompatibility, improved cellular uptake, and reducing off-target side effects. Therefore, lipid-based nanotheranostics are considered an effective and safer option for eradicating breast cancer. This chapter presents an updated description of lipid-based nanoformulations and their applications in breast cancer theranostics.